Indegene Ltd

Ticker: INDGN
Decent 68/100

☆ Add to Watchlist

Investing Reference

Price
575.40
Market Cap
13813.61
Debt/Equity
0.0388
ROE %
20.110
PB
5.2812
Promoter %
0.000
Pledge %
0.000
1Y Rev Growth %
6.780
5Y Rev Growth %
35.423
NP Margin %
13.803
NP Margin 5Y Avg %
12.292

Trading Reference

1M Return %
0.802
6M Return %
6.526
1Y Return %
-13.298
% Away 52W High
27.963
% Away 52W Low
15.311
Daily Volume
388972
Investment Verdict
Risky
Score 56/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 23/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Indegene Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, there is a strong potential for upward movement. However, if it falls below the support, it may face significant downside risk.
Upside Probability: 20%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Indegene Ltd is a leading provider of technology and services for the healthcare industry, catering to pharmaceutical companies, medical device manufacturers, and healthcare providers. With a focus on enhancing patient outcomes and streamlining operations, Indegene leverages innovative solutions to meet the evolving needs of the healthcare sector. This matters as it drives efficiency and improves patient care, making healthcare more accessible and effective. Trust in Indegene for its commitment to quality and its expertise in navigating complex healthcare challenges.

  • Leading healthcare solutions provider
  • Focus on pharmaceutical and medical device sectors
  • Enhances patient outcomes and operational efficiency
  • Innovative technology-driven approach
  • Expertise in navigating healthcare complexities

Investment Thesis

Indegene Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for sustained growth in the healthcare sector, making it a compelling investment opportunity for retail investors.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Significant growth potential in digital healthcare services driven by industry trends.
  • Attractive valuation metrics compared to industry peers suggest upside potential.
  • Established client relationships with leading pharmaceutical companies bolster revenue stability.
  • Strategic focus on innovation positions Indegene for long-term success.

Opportunity vs Risk

Opportunities
  • Growing healthcare digitalization
  • Expanding global client base
  • Strong demand for AI solutions
  • Partnerships with leading pharma companies
Risks ⚠️
  • Regulatory changes in healthcare
  • Intense competition in industry
  • Dependence on key clients
  • Economic downturn affecting budgets

Peer Perspective

Indegene Ltd trades at a slight premium to peers like Cognizant and Wipro, reflecting its strong growth potential. A sustained improvement in margin stability could trigger a rerating, aligning it more closely with industry leaders.

Future Outlook

Indegene Ltd is well-positioned for growth, driven by increasing demand for digital healthcare solutions; however, successful execution of its strategic initiatives and effective cost control will be crucial to maximize shareholder value.

AI FAQs for Retail Users

  • Q: What does Indegene Ltd do?
    A: Indegene Ltd provides technology and services for healthcare and life sciences companies.
  • Q: Is Indegene Ltd a profitable company?
    A: Indegene has reported profitability in recent quarters, but past performance does not guarantee future results.
  • Q: What are the risks of investing in Indegene Ltd?
    A: Risks include market competition, regulatory changes, and dependence on healthcare sector trends.
  • Q: How can I buy shares of Indegene Ltd?
    A: You can buy shares through a registered stockbroker or an online trading platform.
  • Q: What is the outlook for Indegene Ltd?
    A: The outlook depends on market conditions and company performance; always do thorough research.
📊 Stock Investment Checklist (100 Points)
Indegene Ltd • Updated: 2025-09-17 14:20:49
  • 10
    Business
    High
    Indegene operates in the healthcare and life sciences sector, which is future-ready with a clear business model.
  • 10
    Growth
    High
    The company has shown consistent revenue growth over the past few years, although profit growth has been variable.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but OCF has been inconsistent compared to net profit.
  • 8
    Valuation
    High
    Valuation metrics like P/E and P/B are slightly above industry averages, indicating potential overvaluation.
  • 7
    Balance
    High
    The balance sheet shows manageable debt levels, but liquidity could be improved.
  • 6
    Governance
    Good
    Promoter holding is stable, but there are minor concerns regarding disclosures.
  • 5
    Drivers
    Good
    Growth drivers are present, but execution risks remain a concern.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity affecting price action.
Final Score & Verdict
Score 68 / 100 • Decent
Indegene Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability consistency and valuation metrics.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 75/100
  • Growth Potential: 70/100
  • Profitability: 65/100
  • Governance: 80/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.